Monoclonal Antibodies in Preclinical EAE Models of Multiple Sclerosis: A Systematic Review

Monoclonal antibodies (mAb) are promising therapeutics in multiple sclerosis and multiple new candidates have been developed, hence increasing the need for some agreement for preclinical mAb studies. We systematically analyzed publications of experimental autoimmune encephalomyelitis (EAE) studies s...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz, Katja, Geisslinger, Gerd, Tegeder, Irmgard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618641/
https://www.ncbi.nlm.nih.gov/pubmed/28926943
http://dx.doi.org/10.3390/ijms18091992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618641/
https://www.ncbi.nlm.nih.gov/pubmed/28926943
http://dx.doi.org/10.3390/ijms18091992

Ejemplares similares